The initial projects will focus on biomarker for amyotrophic lateral sclerosis (ALS), the molecular basis of neurodevelopmental disorders in schizophrenia and
research on the molecular pathogenesis and neural abnormalities in old age depression
JST news release, December 25, 2013
JST and Israel’s MOST start cooperation program